Literature DB >> 21044449

Use of methotrexate in patients with uveitis.

A Ali1, J T Rosenbaum.   

Abstract

Methotrexate has been frequently employed to treat ocular inflammatory diseases including uveitis, scleritis, and orbital inflammatory disease. It is effective for intraocular lymphoma when given directly into the eye. No study has assessed its efficacy for eye disease in a randomised, placebo controlled design. This report reviews the literature relevant to methotrexate's utility in the treatment of ocular inflammatory disease.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21044449

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  5 in total

Review 1.  The Use of Biologic Therapies in Uveitis.

Authors:  Sergio Schwartzman; Monica Schwartzman
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

2.  Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis.

Authors:  Rupesh Agrawal; Cecilia S Lee; Julio J Gonzalez-Lopez; Sharmina Khan; Valeria Rodrigues; Carlos Pavesio
Journal:  Ocul Immunol Inflamm       Date:  2015-08-26       Impact factor: 3.070

3.  Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis.

Authors:  Martin Roesel; Christoph Tappeiner; Arnd Heiligenhaus; Carsten Heinz
Journal:  Clin Ophthalmol       Date:  2011-09-13

Review 4.  Evidence-based efficacy of methotrexate in adult Crohn's disease in different intestinal and extraintestinal indications.

Authors:  Andrea Cassinotti; Alberto Batticciotto; Marco Parravicini; Maurizio Lombardo; Paolo Radice; Claudio Camillo Cortelezzi; Simone Segato; Federico Zanzi; Antonella Cappelli; Sergio Segato
Journal:  Therap Adv Gastroenterol       Date:  2022-03-23       Impact factor: 4.409

Review 5.  Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye.

Authors:  Michael Mikhail; Ahmed Sallam
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.